Howard W. Robin
2009
In 2009, Howard W. Robin earned a total compensation of $3M as President and Chief Executive Officer at Nektar Therapeutics, a 20% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $1,000,000 |
|---|---|
| Option Awards | $1,257,743 |
| Salary | $730,417 |
| Other | $14,973 |
| Total | $3,003,133 |
Robin received $1.3M in option awards, accounting for 42% of the total pay in 2009.
Robin also received $1M in non-equity incentive plan, $730.4K in salary and $15K in other compensation.
Rankings
In 2009, Howard W. Robin's compensation ranked 1,531st out of 9,885 executives tracked by ExecPay. In other words, Robin earned more than 84.5% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 1,531 out of 9,885 | 85th |
Division Manufacturing | 540 out of 3,690 | 85th |
Major group Chemicals And Allied Products | 107 out of 866 | 88th |
Industry group Drugs | 69 out of 638 | 89th |
Industry Pharmaceutical Preparations | 56 out of 446 | 87th |
Source: SEC filing on April 30, 2012.
Robin's colleagues
We found two more compensation records of executives who worked with Howard W. Robin at Nektar Therapeutics in 2009.